Global Oral Cancer Therapeutics Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	143 Pages	TechNavio	June, 2024	INF19007017

Best Price Guarantee
Price	from $2,500
Length	143 Pages
Publisher	TechNavio
Published Date	June, 2024
SKU	INF19007017

Global Oral Cancer Therapeutics Market 2024-2028

The oral cancer therapeutics market is forecasted to grow by USD 1615.4 mn during 2023-2028, accelerating at a CAGR of 10.03% during the forecast period. The report on the oral cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing incidence and prevalence of oral cancer, increasing risk factors of oral cancer, and growing awareness about oral cancer.

Technavio's oral cancer therapeutics market is segmented as below:

By Product

Targeted therapy
Chemotherapy

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increase r and d of new drugs as one of the prime reasons driving the oral cancer therapeutics market growth during the next few years. Also, development of nanotechnology-based drug delivery system and advancement in cancer screening will lead to sizable demand in the market.

The report on the oral cancer therapeutics market covers the following areas:

Oral cancer therapeutics market sizing
Oral cancer therapeutics market forecast
Oral cancer therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading oral cancer therapeutics market vendors that include Amneal Pharmaceuticals Inc., AstraZeneca Plc, Bristol Myers Squibb Co., Cipla Inc., Eli Lilly and Co., Endo International Plc, F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Lupin Ltd., Merck and Co. Inc., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Viatris Inc.. Also, the oral cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market by Geography; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 2.2 Market characteristics; Market characteristics analysis; 2.3 Value chain analysis; Value Chain Analysis
3 Market Sizing: 3.1 Market definition; Offerings of companies included in the market definition; 3.2 Market segment analysis; Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Chart on Global - Market size and forecast 2023-2028 ($ million); Data Table on Global - Market size and forecast 2023-2028 ($ million); Chart on Global Market: Year-over-year growth 2023-2028 (%); Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global Oral Cancer Therapeutics Market 2018 - 2022; Historic Market Size - Data Table on Global Oral Cancer Therapeutics Market 2018 - 2022 ($ million); 4.2 Product segment analysis 2018 - 2022; Historic Market Size - Product Segment 2018 - 2022 ($ million); 4.3 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.4 Country segment analysis 2018 - 2022; Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product: 6.1 Market segments; Chart on Product - Market share 2023-2028 (%); Data Table on Product - Market share 2023-2028 (%); 6.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 6.3 Targeted therapy - Market size and forecast 2023-2028; Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million); Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million); Chart on Targeted therapy - Year-over-year growth 2023-2028 (%); Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%); 6.4 Chemotherapy - Market size and forecast 2023-2028; Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million); Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million); Chart on Chemotherapy - Year-over-year growth 2023-2028 (%); Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Product; Market opportunity by Product ($ million); Data Table on Market opportunity by Product ($ million)
7 Customer Landscape: 7.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape: 8.1 Geographic segmentation; Chart on Market share by geography 2023-2028 (%); Data Table on Market share by geography 2023-2028 (%); 8.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 8.3 North America - Market size and forecast 2023-2028; Chart on North America - Market size and forecast 2023-2028 ($ million); Data Table on North America - Market size and forecast 2023-2028 ($ million); Chart on North America - Year-over-year growth 2023-2028 (%); Data Table on North America - Year-over-year growth 2023-2028 (%); 8.4 Europe - Market size and forecast 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ million); Data Table on Europe - Market size and forecast 2023-2028 ($ million); Chart on Europe - Year-over-year growth 2023-2028 (%); Data Table on Europe - Year-over-year growth 2023-2028 (%); 8.5 Asia - Market size and forecast 2023-2028; Chart on Asia - Market size and forecast 2023-2028 ($ million); Data Table on Asia - Market size and forecast 2023-2028 ($ million); Chart on Asia - Year-over-year growth 2023-2028 (%); Data Table on Asia - Year-over-year growth 2023-2028 (%); 8.6 Rest of World (ROW) - Market size and forecast 2023-2028; Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 8.7 US - Market size and forecast 2023-2028; Chart on US - Market size and forecast 2023-2028 ($ million); Data Table on US - Market size and forecast 2023-2028 ($ million); Chart on US - Year-over-year growth 2023-2028 (%); Data Table on US - Year-over-year growth 2023-2028 (%); 8.8 Canada - Market size and forecast 2023-2028; Chart on Canada - Market size and forecast 2023-2028 ($ million); Data Table on Canada - Market size and forecast 2023-2028 ($ million); Chart on Canada - Year-over-year growth 2023-2028 (%); Data Table on Canada - Year-over-year growth 2023-2028 (%); 8.9 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ million); Data Table on Germany - Market size and forecast 2023-2028 ($ million); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 8.10 India - Market size and forecast 2023-2028; Chart on India - Market size and forecast 2023-2028 ($ million); Data Table on India - Market size and forecast 2023-2028 ($ million); Chart on India - Year-over-year growth 2023-2028 (%); Data Table on India - Year-over-year growth 2023-2028 (%); 8.11 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ million); Data Table on UK - Market size and forecast 2023-2028 ($ million); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 8.12 Market opportunity by geography; Market opportunity by geography ($ million); Data Tables on Market opportunity by geography ($ million)
9 Drivers, Challenges, and Opportunity/Restraints: 9.1 Market drivers; 9.2 Market challenges; 9.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 9.4 Market opportunities/restraints
10 Competitive Landscape: 10.1 Overview; 10.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 10.3 Landscape disruption; Overview on factors of disruption; 10.4 Industry risks; Impact of key risks on business
11 Competitive Analysis: 11.1 Companies profiled; Companies covered; 11.2 Market positioning of companies; Matrix on companies position and classification; 11.3 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; 11.4 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; 11.5 Cipla Inc.; Cipla Inc. - Overview; Cipla Inc. - Business segments; Cipla Inc. - Key news; Cipla Inc. - Key offerings; Cipla Inc. - Segment focus; 11.6 Eli Lilly and Co.; Eli Lilly and Co. - Overview; Eli Lilly and Co. - Product / Service; Eli Lilly and Co. - Key news; Eli Lilly and Co. - Key offerings; 11.7 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; 11.8 Fresenius SE and Co. KGaA; Fresenius SE and Co. KGaA - Overview; Fresenius SE and Co. KGaA - Business segments; Fresenius SE and Co. KGaA - Key news; Fresenius SE and Co. KGaA - Key offerings; Fresenius SE and Co. KGaA - Segment focus; 11.9 Intas Pharmaceuticals Ltd.; Intas Pharmaceuticals Ltd. - Overview; Intas Pharmaceuticals Ltd. - Product / Service; Intas Pharmaceuticals Ltd. - Key offerings; 11.10 Merck and Co. Inc.; Merck and Co. Inc. - Overview; Merck and Co. Inc. - Business segments; Merck and Co. Inc. - Key news; Merck and Co. Inc. - Key offerings; Merck and Co. Inc. - Segment focus; 11.11 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus; 11.12 Viatris Inc.; Viatris Inc. - Overview; Viatris Inc. - Business segments; Viatris Inc. - Key news; Viatris Inc. - Key offerings; Viatris Inc. - Segment focus
12 Appendix: 12.1 Scope of the report; 12.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 12.3 Currency conversion rates for US$; Currency conversion rates for US$; 12.4 Research methodology; Research methodology; 12.5 Data procurement; Information sources; 12.6 Data validation; Data validation; 12.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 12.8 Data synthesis; Data synthesis; 13.9 360 degree market analysis; 360 degree market analysis; 12.10 List of abbreviations; List of abbreviations

Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market by Geography; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Incremental Growth; Exhibits7: Executive Summary - Data Table on Incremental Growth; Exhibits8: Executive Summary - Chart on Company Market Positioning; Exhibits9: Parent Market; Exhibits10: Data Table on - Parent Market; Exhibits11: Market characteristics analysis; Exhibits12: Value Chain Analysis; Exhibits13: Offerings of companies included in the market definition; Exhibits14: Market segments; Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits19: Historic Market Size - Data Table on Global Oral Cancer Therapeutics Market 2018 - 2022 ($ million); Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on Product - Market share 2023-2028 (%); Exhibits31: Data Table on Product - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by Product; Exhibits33: Data Table on Comparison by Product; Exhibits34: Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million); Exhibits35: Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million); Exhibits36: Chart on Targeted therapy - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million); Exhibits39: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million); Exhibits40: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%); Exhibits42: Market opportunity by Product ($ million); Exhibits43: Data Table on Market opportunity by Product ($ million); Exhibits44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits45: Chart on Market share by geography 2023-2028 (%); Exhibits46: Data Table on Market share by geography 2023-2028 (%); Exhibits47: Chart on Geographic comparison; Exhibits48: Data Table on Geographic comparison; Exhibits49: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits50: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits51: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits52: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits53: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits54: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits55: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits56: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits57: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits58: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits59: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits60: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits65: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits66: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits67: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits68: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits69: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits70: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits71: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits72: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits73: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits74: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits75: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits76: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits77: Chart on India - Market size and forecast 2023-2028 ($ million); Exhibits78: Data Table on India - Market size and forecast 2023-2028 ($ million); Exhibits79: Chart on India - Year-over-year growth 2023-2028 (%); Exhibits80: Data Table on India - Year-over-year growth 2023-2028 (%); Exhibits81: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits82: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits83: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits84: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits85: Market opportunity by geography ($ million); Exhibits86: Data Tables on Market opportunity by geography ($ million); Exhibits87: Impact of drivers and challenges in 2023 and 2028; Exhibits88: Overview on criticality of inputs and factors of differentiation; Exhibits89: Overview on factors of disruption; Exhibits90: Impact of key risks on business; Exhibits91: Companies covered; Exhibits92: Matrix on companies position and classification; Exhibits93: AstraZeneca Plc - Overview; Exhibits94: AstraZeneca Plc - Product / Service; Exhibits95: AstraZeneca Plc - Key news; Exhibits96: AstraZeneca Plc - Key offerings; Exhibits97: Bristol Myers Squibb Co. - Overview; Exhibits98: Bristol Myers Squibb Co. - Product / Service; Exhibits99: Bristol Myers Squibb Co. - Key news; Exhibits100: Bristol Myers Squibb Co. - Key offerings; Exhibits101: Cipla Inc. - Overview; Exhibits102: Cipla Inc. - Business segments; Exhibits103: Cipla Inc. - Key news; Exhibits104: Cipla Inc. - Key offerings; Exhibits105: Cipla Inc. - Segment focus; Exhibits106: Eli Lilly and Co. - Overview; Exhibits107: Eli Lilly and Co. - Product / Service; Exhibits108: Eli Lilly and Co. - Key news; Exhibits109: Eli Lilly and Co. - Key offerings; Exhibits110: F. Hoffmann La Roche Ltd. - Overview; Exhibits111: F. Hoffmann La Roche Ltd. - Business segments; Exhibits112: F. Hoffmann La Roche Ltd. - Key news; Exhibits113: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits114: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits115: Fresenius SE and Co. KGaA - Overview; Exhibits116: Fresenius SE and Co. KGaA - Business segments; Exhibits117: Fresenius SE and Co. KGaA - Key news; Exhibits118: Fresenius SE and Co. KGaA - Key offerings; Exhibits119: Fresenius SE and Co. KGaA - Segment focus; Exhibits120: Intas Pharmaceuticals Ltd. - Overview; Exhibits121: Intas Pharmaceuticals Ltd. - Product / Service; Exhibits122: Intas Pharmaceuticals Ltd. - Key offerings; Exhibits123: Merck and Co. Inc. - Overview; Exhibits124: Merck and Co. Inc. - Business segments; Exhibits125: Merck and Co. Inc. - Key news; Exhibits126: Merck and Co. Inc. - Key offerings; Exhibits127: Merck and Co. Inc. - Segment focus; Exhibits128: Sanofi SA - Overview; Exhibits129: Sanofi SA - Business segments; Exhibits130: Sanofi SA - Key news; Exhibits131: Sanofi SA - Key offerings; Exhibits132: Sanofi SA - Segment focus; Exhibits133: Viatris Inc. - Overview; Exhibits134: Viatris Inc. - Business segments; Exhibits135: Viatris Inc. - Key news; Exhibits136: Viatris Inc. - Key offerings; Exhibits137: Viatris Inc. - Segment focus; Exhibits138: Inclusions checklist; Exhibits139: Exclusions checklist; Exhibits140: Currency conversion rates for US$; Exhibits141: Research methodology; Exhibits142: Information sources; Exhibits143: Data validation; Exhibits144: Validation techniques employed for market sizing; Exhibits145: Data synthesis; Exhibits146: 360 degree market analysis; Exhibits147: List of abbreviations